Search Results | Diabetes | American Diabetes Association

1-20 of 72

Sort by

Sort Order Select

Journal Articles

K_ATP Channels and the Metabolic Regulation of Insulin Secretion in Health and Disease: The 2022 Banting Medal for Scientific Achievement Award Lecture

Frances M. Ashcroft

Diabetes 2023;72(6):693–702

DOI: https://doi.org/10.2337/dbi22-0030

Published: 19 May 2023

View article titled, K<sub>ATP</sub> Channels and the Metabolic Regulation of Insulin Secretion in Health and Disease: The 2022 Banting Medal for Scientific Achievement Award Lecture

Meeting Abstracts

204-OR: The Chd4 Helicase Modulates ß-Cell Function In Vivo

REBECCA K. DAVIDSON, NOLAN CASEY, SUKRATI KANOJIA, JASON SPAETH

Diabetes 2022;71(Supplement_1):204-OR

DOI: https://doi.org/10.2337/db22-204-OR

Published: 01 June 2022

View article titled, 204-OR: The Chd4 Helicase Modulates ß-Cell Function In Vivo

Meeting Abstracts

5-LB: Dulaglutide in Youth with Type 2 Diabetes (T2D) —Results of the AWARD-PEDS Randomized, Placebo-Controlled Trial

SILVA A. ARSLANIAN, JANG IK CHO, TAMARA S. HANNON, PHILIP ZEITLER, LILY CHAO, MARGARITA BARRIENTOS, CLAUDIA C. BOUCHER-BERRY, ELISE BISMUTH, SERGIO A. DIB, DAVID COX

Diabetes 2022;71(Supplement_1):5-LB

DOI: https://doi.org/10.2337/db22-5-LB

Published: 01 June 2022

View article titled, 5-LB: Dulaglutide in Youth with Type 2 Diabetes (T2D) —Results of the AWARD-PEDS Randomized, Placebo-Controlled Trial

Journal Articles

Women and the American Diabetes Association

Cynthia E. Munoz, Ruth S. Weinstock, Tracey D. Brown, Robert A. Gabbay

Diabetes 2021;70(8):1638–1639

DOI: https://doi.org/10.2337/dbi21-0024

Published: 15 June 2021

View article titled, Women and the American Diabetes Association

Journal Articles

Career Advancement for Women in Diabetes-Related Research: Developing and Retaining Female Talent

Darleen A. Sandoval, Laura C. Alonso, Maureen Gannon, Maike Sander, Lori Sussel, Jane E.B. Reusch

Diabetes 2021;70(8):1634–1637

DOI: https://doi.org/10.2337/dbi21-0023

Published: 15 June 2021

View article titled, Career Advancement for Women in Diabetes-Related Research: Developing and Retaining Female Talent

Journal Articles

The Women’s Leadership Gap in Diabetes: A Call for Equity and Excellence

Jessica L. Dunne, Jennifer L. Maizel, Amanda L. Posgai, Mark A. Atkinson, Linda A. DiMeglio

Diabetes 2021;70(8):1623–1633

DOI: https://doi.org/10.2337/db21-0052

Published: 15 June 2021

View article titled, The Women’s Leadership Gap in Diabetes: A Call for Equity and Excellence

Meeting Abstracts

229-LB: Quantification of GLP-1R Internalization and Recycling in Live ß Cells

SARAH M. GRAY, KYLE SLOOP, PETER RAVN, JONATHAN CAMPBELL, DAVID A. D’ALESSIO

Diabetes 2021;70(Supplement_1):229-LB

DOI: https://doi.org/10.2337/db21-229-LB

Published: 01 June 2021

View article titled, 229-LB: Quantification of GLP-1R Internalization and Recycling in Live ß Cells

Meeting Abstracts

680-P: Once-Weekly Dulaglutide 3 mg and 4.5 mg Gastrointestinal Tolerability: Post-hoc Analysis of Incidence and Prevalence in Award-11

JOANNA VAN, JUAN P. FRIAS, ENZO BONORA, SOHINI RAHA, HEIKE JUNG, DAVID COX, MANIGE KONIG, JENNIFER PELESHOK

Diabetes 2021;70(Supplement_1):680-P

DOI: https://doi.org/10.2337/db21-680-P

Published: 01 June 2021

View article titled, 680-P: Once-Weekly Dulaglutide 3 mg and 4.5 mg Gastrointestinal Tolerability: Post-hoc Analysis of Incidence and Prevalence in Award-11

Meeting Abstracts

651-P: Higher Doses of Dulaglutide Induce Weight Loss in Patients with Type 2 Diabetes (T2D) Regardless of Baseline BMI: Post-hoc Analysis of AWARD-11

ENZO BONORA, JUAN P. FRIAS, RALEIGH MALIK, ANITA KWAN, SOHINI RAHA, ANGELYN BETHEL, DAVID COX

Diabetes 2021;70(Supplement_1):651-P

DOI: https://doi.org/10.2337/db21-651-P

Published: 01 June 2021

View article titled, 651-P: Higher Doses of Dulaglutide Induce Weight Loss in Patients with Type 2 Diabetes (T2D) Regardless of Baseline BMI: Post-hoc Analysis of AWARD-11

Meeting Abstracts

673-P: Effect of Once-Weekly Dulaglutide 3.0 and 4.5 mg in Patients with Different Baseline Renal Function: Post-hoc Analysis from the Award-11 Trial

LUIS-EMILIO GARCIA-PEREZ, JUAN M. MALDONADO, KARI T. RANTA, SOHINI RAHA

Diabetes 2021;70(Supplement_1):673-P

DOI: https://doi.org/10.2337/db21-673-P

Published: 01 June 2021

View article titled, 673-P: Effect of Once-Weekly Dulaglutide 3.0 and 4.5 mg in Patients with Different Baseline Renal Function: Post-hoc Analysis from the Award-11 Trial

Meeting Abstracts

357-OR: Efficacy and Safety of Dulaglutide 3mg and 4.5mg vs. Dulaglutide 1.5mg: 52-Week Results from AWARD-11

JUAN P. FRIAS, ENZO BONORA, LUIS A. NEVAREZ RUIZ, GRACE LI, ZHUOXIN YU, ZVONKO MILICEVIC, RALEIGH MALIK, ANGELYN BETHEL, DAVID COX

Diabetes 2020;69(Supplement_1):357-OR

DOI: https://doi.org/10.2337/db20-357-OR

Published: 01 June 2020

View article titled, 357-OR: Efficacy and Safety of Dulaglutide 3mg and 4.5mg vs. Dulaglutide 1.5mg: 52-Week Results from AWARD-11

Meeting Abstracts

1056-P: Effect of Dulaglutide on Glycemic Variability: Post Hoc Analysis of the AWARD Studies

ESTEBAN JODAR, QIANQIAN WANG, IRENE ROMERA, ELENA CAVEDA, LUIS EMILIO GARCIA

Diabetes 2020;69(Supplement_1):1056-P

DOI: https://doi.org/10.2337/db20-1056-P

Published: 01 June 2020

View article titled, 1056-P: Effect of Dulaglutide on Glycemic Variability: Post Hoc Analysis of the AWARD Studies

Meeting Abstracts

233-OR: Chronic Kidney Disease (CKD) Outcomes with Dulaglutide (DU) vs. Insulin Glargine (IG) in Type 2 Diabetes (T2D) and Moderate-to-Severe CKD by Albuminuria Status: AWARD-7

KATHERINE R. TUTTLE, BRIAN L. RAYNER, MARK LAKSHMANAN, BRAD WOODWARD, ANITA KWAN, MANIGE KONIG, FADY T. BOTROS

Diabetes 2019;68(Supplement_1):233-OR

DOI: https://doi.org/10.2337/db19-233-OR

Published: 01 June 2019

View article titled, 233-OR: Chronic Kidney Disease (CKD) Outcomes with Dulaglutide (DU) vs. Insulin Glargine (IG) in Type 2 Diabetes (T2D) and Moderate-to-Severe CKD by Albuminuria Status: AWARD-7

Journal Articles

Issues and Events

Diabetes 2019;68(2):467

DOI: https://doi.org/10.2337/db19-ie02

Published: 14 January 2019

View article titled, Issues and Events

Meeting Abstracts

Treatment Effects of Once-Weekly Dulaglutide vs. Insulin Glargine in Patients with Different Baseline Glycemic Patterns (Based on High/Low Fasting or High/Low Postprandial Glucose)—A Post-Hoc Analysis of the AWARD-2 Clinical Trial

FRANCESCO GIORGINO, MARIA YU, AXEL HAUPT, ZVONKO MILICEVIC, LUIS-EMILIO GARCIA-PEREZ

Diabetes 2018;67(Supplement_1):1007-P

DOI: https://doi.org/10.2337/db18-1007-P

Published: 01 July 2018

View article titled, Treatment Effects of Once-Weekly Dulaglutide vs. Insulin Glargine in Patients with Different Baseline Glycemic Patterns (Based on High/Low Fasting or High/Low Postprandial Glucose)—A Post-Hoc Analysis of the AWARD-2 Clinical Trial

Meeting Abstracts

Lesser eGFR Decline with Dulaglutide Regardless of Weight Changes in People with Type 2 Diabetes and Moderate to Severe Chronic Kidney Disease (AWARD-7)

KATHERINE R. TUTTLE, MARK LAKSHMANAN, BRIAN L. RAYNER, ROBERT S. BUSCH, ALAN G. ZIMMERMANN, BRAD WOODWARD, FADY T. BOTROS

Diabetes 2018;67(Supplement_1):1066-P

DOI: https://doi.org/10.2337/db18-1066-P

Published: 01 July 2018

View article titled, Lesser eGFR Decline with Dulaglutide Regardless of Weight Changes in People with Type 2 Diabetes and Moderate to Severe Chronic Kidney Disease (AWARD-7)

Journal Articles

Metabolic Karma—The Atherogenic Legacy of Diabetes: The 2017 Edwin Bierman Award Lecture

Mark Emmanuel Cooper, Assam El-Osta, Terri Jean Allen, Anna Margareta Dorothea Watson, Merlin Christopher Thomas, Karin Agnes Maria Jandeleit-Dahm

Diabetes 2018;67(5):785–790

DOI: https://doi.org/10.2337/dbi18-0010

Published: 13 April 2018

View article titled, Metabolic Karma—The Atherogenic Legacy of Diabetes: The 2017 Edwin Bierman Award Lecture

Journal Articles

Cellular Energy Sensing and Metabolism—Implications for Treating Diabetes: The 2017 Outstanding Scientific Achievement Award Lecture

Gregory R. Steinberg

Diabetes 2018;67(2):169–179

DOI: https://doi.org/10.2337/dbi17-0039

Published: 16 January 2018

View article titled, Cellular Energy Sensing and Metabolism—Implications for Treating Diabetes: The 2017 Outstanding Scientific Achievement Award Lecture

Journal Articles

Issues and Events

Diabetes 2017;66(7):2060

DOI: https://doi.org/10.2337/db17-ie07

Published: 15 June 2017

View article titled, Issues and Events

Journal Articles

We Know More Than We Can Tell About Diabetes and Vascular Disease: The 2016 Edwin Bierman Award Lecture

Clay F. Semenkovich

Diabetes 2017;66(7):1735–1741

DOI: https://doi.org/10.2337/db17-0093

Published: 15 June 2017

View article titled, We Know More Than We Can Tell About Diabetes and Vascular Disease: The 2016 Edwin Bierman Award Lecture

NARROW

K_ATP Channels and the Metabolic Regulation of Insulin Secretion in Health and Disease: The 2022 Banting Medal for Scientific Achievement Award Lecture

204-OR: The Chd4 Helicase Modulates ß-Cell Function In Vivo

5-LB: Dulaglutide in Youth with Type 2 Diabetes (T2D) —Results of the AWARD-PEDS Randomized, Placebo-Controlled Trial

Women and the American Diabetes Association

Career Advancement for Women in Diabetes-Related Research: Developing and Retaining Female Talent

The Women’s Leadership Gap in Diabetes: A Call for Equity and Excellence

229-LB: Quantification of GLP-1R Internalization and Recycling in Live ß Cells

680-P: Once-Weekly Dulaglutide 3 mg and 4.5 mg Gastrointestinal Tolerability: Post-hoc Analysis of Incidence and Prevalence in Award-11

651-P: Higher Doses of Dulaglutide Induce Weight Loss in Patients with Type 2 Diabetes (T2D) Regardless of Baseline BMI: Post-hoc Analysis of AWARD-11

673-P: Effect of Once-Weekly Dulaglutide 3.0 and 4.5 mg in Patients with Different Baseline Renal Function: Post-hoc Analysis from the Award-11 Trial

357-OR: Efficacy and Safety of Dulaglutide 3mg and 4.5mg vs. Dulaglutide 1.5mg: 52-Week Results from AWARD-11

1056-P: Effect of Dulaglutide on Glycemic Variability: Post Hoc Analysis of the AWARD Studies

233-OR: Chronic Kidney Disease (CKD) Outcomes with Dulaglutide (DU) vs. Insulin Glargine (IG) in Type 2 Diabetes (T2D) and Moderate-to-Severe CKD by Albuminuria Status: AWARD-7

Issues and Events

Treatment Effects of Once-Weekly Dulaglutide vs. Insulin Glargine in Patients with Different Baseline Glycemic Patterns (Based on High/Low Fasting or High/Low Postprandial Glucose)—A Post-Hoc Analysis of the AWARD-2 Clinical Trial

Lesser eGFR Decline with Dulaglutide Regardless of Weight Changes in People with Type 2 Diabetes and Moderate to Severe Chronic Kidney Disease (AWARD-7)

Metabolic Karma—The Atherogenic Legacy of Diabetes: The 2017 Edwin Bierman Award Lecture

Cellular Energy Sensing and Metabolism—Implications for Treating Diabetes: The 2017 Outstanding Scientific Achievement Award Lecture

Issues and Events

We Know More Than We Can Tell About Diabetes and Vascular Disease: The 2016 Edwin Bierman Award Lecture

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only